N2-Phenyl-9-(hydroxyalkyl)guanines and related compounds are substrates for Herpes simplex thymidine kinases

Andrea Lossani, Lida Savi, Andrzej Manikowski, Andrew Maioli, Joseph Gambino, Federico Focher, Silvio Spadari, George E Wright

Abstract


Herpes simplex virus (HSV) types 1 and 2 thymidine kinases (TK) are responsible for phosphorylation of antiherpes acyclonucleosides such as acyclovir (ACV) and 9-(4-hydroxybutyl)guanine (HBG). Related compounds, the N2-phenyl-9-(hydroxyalkyl)guanines, are devoid of direct antiviral activity, but potently inhibit the viral TKs and block viral reactivation from latency in vivo. The similarity in structure between the acyclonucleosides and TK inhibitors raised the question of the relevance of phosphorylation of certain of the latter analogs in their mechanisms of action. Using recombinant TKs and HPLC analysis of reaction mixtures, we report that the lead TK inhibitor N2-phenyl-9-(4-hydroxybutyl)guanine (HBPG) and its pentyl homolog (HPnPG) are excellent substrates for the enzymes, approaching the efficiency with which the natural substrate thymidine is phosphorylated, and significantly better than ACV or HBG. Other 9-hydroxyalkyl congeners are substrates for the enzymes, but with much poorer efficiency. HBPG triphosphate was a poor inhibitor of HSV DNA polymerase, the target of acyclonucleoside triphosphates, suggesting that phosphorylation of HBPG is not important in its mechanism of blocking viral reactivation in vivo. The fact that HBPG is an efficient substrate is consistent, however, with its binding mode based both on molecular modeling studies and x-ray structure of the HBPG:TK complex.


Keywords


Herpesvirus; phosphorylation; substrate; antiviral; reactivation

References


Bennett MS, Wien F, Champness JN, Batuwangala T, Ruth-erford T, Summers WC, Sun H, Wright G & Sanderson MR 1999 Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir. FEBS Lett 443 121-125.

Focher F, Hildebrand C, Freese S, Ciarrocchi G, Noonan T, Sangalli S, Brown NC, Spadari S & Wright G 1988 N 2-Phenyldeoxyguanosine: a novel selective inhibitor of Herpes simplex thymidine kinase. J Med Chem 31 1496-1500.

Focher F, Lossani A, Torti A, Gambino G & Wright GE 2011 Binding Modes of 2-Phenylamino-6-oxopurines to Herpes Simplex Virus Thymidine Kinases. Lett Drug Design Disc 8 1-8.

Focher F, Verri A, Verzeletti S, Mazzarello P & Spadari S 1992 Uracil in OriS of herpes simplex 1 alters its specific recognition by origin binding protein (OBP): does virus induced uracil-DNA glycosylase play a key role in viral reactivation and replication? Chromosoma 102 67-71.

Furman PA, St Clair MH, Fyfe JA, Rideout JL, Keller PM & Elion GB 1979 Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphos-phate. J Virol 32 72-77.

Gebhardt BM, Wright GE, Xu H, Focher F, Spadari S & Kaufman HE 1996 9-(4-Hydroxybutyl)-N 2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice. Antiviral Res 30 87-94.

Hildebrand C, Sandoli D, Focher F, Gambino J, Ciarrocchi G, Spadari S & Wright G 1990 Structure-activity relationships of N 2-substituted guanines as inhibitors of HSV1 and HSV2 thymidine kinases. J Med Chem 33 203-206.

Keller PM, Fyfe JA, Beauchamp L, Lubbers CM, Furman PA, Schaeffer HJ & Elion GB 1981 Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with anti-herpetic activities. Biochem Pharmacol 30 3071-3077.

Larsson A, Alenius S, Johansson NG & Oberg B 1983 Anti-herpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res 3 77-86.

Manikowski A, Verri A, Lossani A, Gebhardt BM, Gam-bino J, Focher F, Spadari S & Wright GE 2005 Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo. J Med Chem 48 3919-3929.

Reardon JE & Spector T 1989 Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J Biol Chem 264 7405-7411.

Sawai H, Ozaki-Nakamura A, Mine M & Ozaki H 2002 Synthesis of New Modified DNAs by Hyperthermophilic DNA Polymerase: Substrate and Template Specificity of Functionalized Thymidine Analogues Bearing an sp3-Hybridized Carbon at the C5 a-Position for Several DNA Polymerases. Bioconjugate Chem 13 309-316.

Yanachkov IB, Dix EJ, Yanachkova MI, Dvoskin S, Xu WC, Gebhardt BM & Wright GE 2011 Herpes simplex virus thymidine kinase inhibitor GLS122E and its 6-deoxy prod-rug GLS361B (Sacrovir™) - potential for preventing viral disease recurrence in vivo. Antiviral Res 90 A77-A78.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright © 2017 Lorem Ipsum Press